Efficacy and Safety of STG320 Sublingual Tablets of House Dust Mite (HDM) Allergen Extracts in Adults and Adolescents With HDM-associated Allergic Rhinitis



Status:Completed
Conditions:Allergy
Therapuetic Areas:Otolaryngology
Healthy:No
Age Range:12 - 65
Updated:9/13/2018
Start Date:September 29, 2015
End Date:June 21, 2018

Use our guide to learn which trials are right for you!

A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Efficacy and Safety of STG320 Sublingual Tablets of House Dust Mite (HDM) Allergen Extracts in Adults and Adolescents With HDM-associated Allergic Rhinitis

The objective of this study is to assess the efficacy and safety of 12 months of treatment
with 300 IR of STG320 sublingual tablets compared with placebo in adults and adolescents with
HDM-associated allergic rhinitis.


Main Inclusion Criteria:

- Patients with HDM-associated allergic rhinitis (AR) for at least 1 year

- Patients sensitized to D. pteronyssinus (D. pte) and/or D. farinae (D. far) defined on
skin prick test and HDM-specific serum IgE

Main Exclusion Criteria:

- A history of rhinitis, rhinoconjunctivitis or asthma to allergens other than HDM,
likely to result in rhinitis symptoms during the evaluation periods

- Partly controlled or uncontrolled asthma

- Controlled asthma requiring controller treatment(s) consistent with GINA 2014
treatment Steps 3 to 5
We found this trial at
2
sites
Montpellier, 34295
Phone: +33 (0)4 67 04 20 20
?
mi
from
Montpellier,
Click here to add this to my saved trials
4202 E Fowler Ave
Tampa, Florida 33620
(813) 974-2011
University of South Florida The University of South Florida is a high-impact, global research university...
?
mi
from
Tampa, FL
Click here to add this to my saved trials